Brexit causing 'undue stress' to those with rare diseases, say patient groups

Brexit uncertainty is causing undue stress to Irish people with rare diseases according to patient advocacy groups.

Brexit causing 'undue stress' to those with rare diseases, say patient groups

Brexit uncertainty is causing undue stress to Irish people with rare diseases according to patient advocacy groups.

Around 300,000 people in Ireland will develop a rare disease at some point in their lives.

European citizens currently have access to a network of experts based in centres across the EU.

CEO of Retina International Avril Daly says Irish patients still do not know if they can access UK-based experts post-Brexit.

"If there was a world leader in a specific rare disease that is based in the UK, is there going to be the same access? Is it going to become much more complex?" asked Ms Daly.

"Patients with rare diseases have a lot of stress on them."

Ms Daly said that the networking of services was introduced in order to be able to alleviate problems in accessing the appropriate care.

more courts articles

DUP calls for measures to prevent Northern Ireland from becoming 'magnet' for asylum seekers DUP calls for measures to prevent Northern Ireland from becoming 'magnet' for asylum seekers
UK's Illegal Migration Act should be disapplied in Northern Ireland, judge rules UK's Illegal Migration Act should be disapplied in Northern Ireland, judge rules
Former prisoner given indefinite hospital order for killing Irishman in London Former prisoner given indefinite hospital order for killing Irishman in London

More in this section

Irish Migration Asylum seeker tents not removed because of Europa League final, insists minister
Road safety Fresh appeal issued for information about car connected to fatal Mayo crash
AS Roma v Bayer 04 Leverkusen: Semi-Final First Leg - UEFA Europa League 2023/24 Gardaí to set up large-scale traffic plan ahead of Europa League final in Aviva Stadium
War_map
Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited